Brief quote from Bob Lanza on Ocata acquisition by Astellas
I asked Ocata CSO, Bob Lanza, for a comment on the big news of the acquisition of the company by Astellas. Here’s what he had to say: “I can say that this is an exciting time for regenerative medicine. The merger should greatly accelerate the pace of discovery, and, I hope, lead to treatments for […]
Brief quote from Bob Lanza on Ocata acquisition by Astellas Read More »